Drug Type TCR-T Cell therapy |
Synonyms |
Target |
Action inhibitors |
Mechanism KKLC1 inhibitors(Kita-Kyushu lung cancer antigen-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | Norway | 28 Aug 2024 | |
Lung Cancer | Preclinical | Norway | 28 Aug 2024 | |
Pancreatic Cancer | Preclinical | Norway | 28 Aug 2024 | |
Stomach Cancer | Preclinical | Norway | 28 Aug 2024 | |
Uterine Cervical Cancer | Preclinical | Norway | 28 Aug 2024 |